focus -WSS

focus

author：explore 2025-09-03 14:43:48 - browse：92

New Sanofi Genzyme president Bill Sibold is the first person without any ties to Henri Termeer (inset) to lead the company. Jonathan Wiggs/Globe staff

CAMBRIDGE, Mass. — When drug giant Sanofi restructured its global business two years ago, its Genzyme division got a new name, Sanofi Genzyme, explicitly tying it to the French parent company. It also got new responsibilities and a larger “specialty care” portfolio covering everything from enzyme replacement to cancer and multiple sclerosis drugs.

Last week, Sanofi Genzyme — still the largest Massachusetts biotech, with about 5,000 workers — also got a new president, Bill Sibold. He’s the first one without any ties to the old Genzyme, an independent company that pioneered the rare-disease business model and catalyzed the local life sciences boom before accepting Sanofi’s $20.1 billion takeover offer in 2011.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： A new deal aims to ramp up use of AI in rehab care decisions

WSS

What is the Turing Test that determines if computers can think?

The nurse manager staffing crisis is hurting patients

The SUPPORT Act is critical to fighting the opioid crisis

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Heart disease and mental health: A look at cardiac psychology

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

hotspot

focus

entertainment

Wildfire smoke exposes gaps in outdoor worker protections

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

Wildfire smoke exposes gaps in outdoor worker protections

The SUPPORT Act is critical to fighting the opioid crisis

Tori Bowie and the unacceptable rates of Black maternal death

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

In Memoriam: Notable people who died in 2023

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

Wildfire smoke exposes gaps in outdoor worker protections

GSK to buy asthma

focus

Designating disabled people as health disparity population is crucial

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

What is the Turing Test that determines if computers can think?

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

HHS names first

hotspot

focus

hotspot

hotspot